Microbiome Therapeutics Market By Type (Fecal Microbial Transplant [FMT], Drugs) By Application (C. difficile, Crohn’s Disease, Inflammatory Bowel Disease [IBD], Diabetes), By Region, And Segment Forecasts, 2018 - 2025Report

Microbiome Therapeutics Market By Type (Fecal Microbial Transplant [FMT], Drugs) By Application (C. difficile, Crohn’s Disease, Inflammatory Bowel Disease [IBD], Diabetes), By Region, And Segment Forecasts, 2018 - 2025

  • Published Date: Dec, 2016
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-311-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 80

Market Segmentation

  • Microbiome Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)
    • FMT
    • Microbiome Drugs
  • Microbiome Therapeutics Market Application Outlook (Revenue, USD Million, 2014 - 2025)
    • C. difficile
    • Crohn’s disease
    • Inflammatory Bowel Disease
    • Diabetes
    • Others
  • Microbiome Therapeutics Market Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • U.S.
        • U.S. Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • U.S. Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
      • Canada
        • Canada Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • Canada Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
    • Europe
      • UK
        • UK Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • UK Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
      • Germany
        • Germany Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • Germany Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
    • Asia Pacific
      • Japan
        • Japan Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • Japan Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
      • China
        • China Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • China Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
      • India
        • India Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • India Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
    • Latin America
      • Brazil
        • Brazil Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • Brazil Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
      • Mexico
        • Mexico Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • Mexico Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
    • MEA
      • South Africa
        • South Africa Type Outlook (Revenue, USD Million, 2014 - 2025)
          • FMT
          • Microbiome Drugs
        • South Africa Application Outlook (Revenue, USD Million, 2014 - 2025)
          • C. difficile
          • Crohn’s disease
          • Inflammatory Bowel Disease
          • Diabetes
          • Others
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.